Melatonin and the aging brain

Area of Science:

• Neuroscience
• Gerontology
• Pharmacology

Background:

• Brain aging involves increased oxidative stress, inflammation, and mitochondrial dysfunction.
• These factors are exacerbated in age-related neurological diseases, suggesting common therapeutic targets.
• Melatonin has shown promise in preclinical models of neurodegeneration.

Purpose of the Study:

• To review the role of melatonin in mitigating age-related brain changes.
• To explore the mechanisms behind melatonin's neuroprotective effects.
• To assess melatonin's potential for treating brain aging and neurodegenerative disorders.

Main Methods:

• Literature review focusing on studies involving melatonin and brain aging/neurodegeneration.
• Analysis of preclinical data from animal and cell culture models.
• Examination of proposed molecular mechanisms of melatonin action.

Main Results:

• Melatonin application in models shows neuroprotective benefits.
• Key mechanisms include melatonin receptor activation, transcription factor modulation, and altered gene expression.
• Enhanced antioxidant enzyme activity and reduced inflammation are observed.

Conclusions:

• Melatonin demonstrates potential for slowing normal brain aging.
• It may serve as a therapeutic agent for neurodegenerative conditions.
• Low cost and low toxicity further support its utility.